CoreCap Advisors’s Guardant Health GH Stock Holding History

CoreCap Advisors’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$10.9K	Hold	61	–	–	﹤0.01%	2031
2026 Q2	$9.15K	Hold	61	–	–	﹤0.01%	2095
2026 Q1	$5.63K	Hold	61	–	–	﹤0.01%	2149
2025 Q4	$6.23K	Hold	61	–	–	﹤0.01%	2119
2025 Q3	$3.81K	Hold	61	–	–	﹤0.01%	2235
2025 Q2	$3.17K	Hold	61	–	–	﹤0.01%	2229
2025 Q1	$2.6K	Buy	61 +1	+2%	+$43	﹤0.01%	2284
2024 Q4	$1.83K	Buy	60 +50	+500%	+$1.41K	﹤0.01%	2250
2024 Q3	$229	Hold	10	–	–	﹤0.01%	2486
2024 Q2	$289	Buy	10 +3	+43%	+$70	﹤0.01%	1490
2024 Q1	$144	Buy	+7	New	+$150	﹤0.01%	2426
2022 Q4	$381	Buy	+14	New	+$641	﹤0.01%	2204
2022 Q3	–	Sell	-14	Closed	-$1K	–	1123
2022 Q2	$1K	Buy	+14	New	+$694	﹤0.01%	1987

Other funds holding GH

MAG

MRA Advisory Group Parsippany, New Jersey $267M AUM 19.2% 1-Year Est. Return

FFAS

FIG Financial Advisory Services Oklahoma City, Oklahoma $165M AUM 16.79% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

CPBTD

Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return

GAA

Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return

WoodTrust Financial Wisconsin Rapids, Wisconsin $825M AUM 20.13% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

WWM

Whalen Wealth Management Las Vegas, Nevada $234M AUM 28.06% 1-Year Est. Return

BTWM

Baker Tilly Wealth Management Madison, Wisconsin $510M AUM 18.32% 1-Year Est. Return

CoreCap Advisors's GH Position: Q3 2026 in Review

CoreCap Advisors held its Guardant Health (GH) position steady in Q3 2026 at 61 shares worth $10.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2031.

CoreCap Advisors first reported a position in GH in Q2 2022 and has held it in 13 quarters since. 19 funds tracked by Wall St. Rank hold GH as of Q3 2026.

CoreCap Advisors held 61 shares of Guardant Health worth $10.9K as of Q3 2026.
CoreCap Advisors left its Guardant Health share count unchanged in Q3 2026.
Guardant Health made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #2031 holding.
CoreCap Advisors first reported a position in Guardant Health in Q2 2022 and has held it in 13 quarters since.
19 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.